A case of spastic paraplegia type 11 mimicking a GM2-gangliosidosis
- PMID: 35066644
- DOI: 10.1007/s10072-021-05841-8
A case of spastic paraplegia type 11 mimicking a GM2-gangliosidosis
Abstract
Introduction: Spastic paraplegia type 11 (SPG11) is the most frequent autosomal recessive HSP. Studies on SPG11 patients' fibroblasts, post-mortem brains, and mouse models revealed endolysosomal system dysfunction and lipid accumulation, especially gangliosides. We report a patient with early clinical findings mimicking a GM2-gangliosidosis.
Methods: A clinical, biochemical, and metabolic characterization was performed. Electron microscopy analysis was completed on rectal mucosa and skin biopsy specimens. A NGS panel of genes associated to neuronal ceroid lipofuscinosis and HSP was analyzed.
Results: The patient presented with worsening walking difficulty and psychomotor slowdown since childhood; to exclude a neurometabolic storage disease, skin and rectal biopsies were performed: enteric neurons showed lipofuscin-like intracellular inclusions, thus suggesting a possible GM2-gangliosidosis. However, further analysis did not allow to confirm such hypothesis. In adulthood we detected flaccid paraplegia, nystagmus, axonal motor neuropathy, carpus callosum atrophy, and colon atony. Surprisingly, the NGS panel detected two already reported SPG11 mutations in compound heterozygosity.
Conclusions: We describe for the first time pathological hallmarks of SPG11 in enteric neuron from a rectal mucosa biopsy. The report illustrates the possible overlap between SPG11 and GM2-gangliosidosis, especially in the first disease phases and helps to improve our knowledge about SPG11 physiopathology.
Keywords: GM2-gangliosidosis; Lipofuscin-like inclusions; Spastic paraplegia type 11.
© 2021. Fondazione Società Italiana di Neurologia.
References
-
- Stevanin G, Azzedine H, Denora P et al (2008) Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 131(3):772–784. https://doi.org/10.1093/brain/awm293 - DOI - PubMed
-
- Pérez-Brangulí F, Mishra HK, Prots I et al (2014) Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum Mol Genet 23(18):4859. https://doi.org/10.1093/HMG/DDU200 - DOI - PubMed - PMC
-
- Renvoisé B, Chang J, Singh R et al (2014) Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Transl Neurol 1(6):379. https://doi.org/10.1002/ACN3.64 - DOI - PubMed - PMC
-
- Branchu J, Boutry M, Sourd L et al (2017) Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration. Neurobiol Dis 102:21. https://doi.org/10.1016/J.NBD.2017.02.007 - DOI - PubMed - PMC
-
- Denora PS, Smets K, Zolfanelli F et al (2016) Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions. Brain 139(6):1723–1734. https://doi.org/10.1093/brain/aww061 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
